High-dose group in psilocybin double-blind study
The high dose group was administered a high dose that accounted for 22 to 30mg for every 70kg, and administered with a low dose in the second session which accounts for 1 to 3 mg dose for every the first session to simulate a placebo.
0
1
Tags
Behavioral Neuroscience
Psychology
Neuroscience (Neurobiology)
Social Science
Empirical Science
Science
Life Science / Biology
Biomedical Sciences
Natural Science
Health Psychology
SARS-CoV-2 (COVID-19)
Related
Low-dose group in a double-blind study of psilocybin's effects in depressive and anxiety symptoms
Low-dose group in psilocybin double-blind study
High-dose group in psilocybin double-blind study
6 month follow-up in psilocybin double-blind study
Control of physiological measures in psilocybin double-blind study